Clinical Trials Browser

Phase 2 × Melanoma × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all

NCT02334735 2022-09-15

A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence

Phase 2 Completed

Melanoma

NCT01876212 2019-08-22

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Phase 2 Completed

15 enrolled 26 charts

Melanoma, Neoplasm Metastasis